Nektar Therapeutics
NKTR
#6154
Rank
โ‚ฌ0.76 B
Marketcap
37,68ย โ‚ฌ
Share price
2.25%
Change (1 day)
190.44%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -6,99ย โ‚ฌ

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -6,75ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -7,51ย โ‚ฌ an increase over its 2023 EPS that were of -18,56ย โ‚ฌ.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-6,99ย โ‚ฌ-6.89%
2024-7,51ย โ‚ฌ-59.54%
2023-18,56ย โ‚ฌ-25.89%
2022-25,04ย โ‚ฌ-31.12%
2021-36,36ย โ‚ฌ14.86%
2020-31,65ย โ‚ฌ-1.19%
2019-32,04ย โ‚ฌ-163.96%
201850,09ย โ‚ฌ-725.4%
2017-8,01ย โ‚ฌ-42.73%
2016-13,98ย โ‚ฌ83.33%
2015-7,63ย โ‚ฌ39.53%
2014-5,47ย โ‚ฌ-69.29%
2013-17,80ย โ‚ฌ-6.67%
2012-19,07ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
11,04ย โ‚ฌ-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,46ย โ‚ฌ-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,44ย โ‚ฌ-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
0,008475ย โ‚ฌ-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
2,57ย โ‚ฌ-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-0,56ย โ‚ฌ-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
1,75ย โ‚ฌ-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
8,85ย โ‚ฌ-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA